U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07859098) titled 'Examining a New Insomnia Treatment for People Living With Secondary Breast Cancer.' on Sept. 23.

Brief Summary: The purpose of this trial is to evaluate an intervention designed to improve insomnia and sleep in people living with secondary breast cancer. The study will assess whether the intervention is feasible and acceptable to deliver and participate in, and whether it may improve sleep and related outcomes.

The main questions the study aims to answer are:

1. Is it feasible to recruit people with secondary breast cancer to take part in the trial?;

2. Is the intervention feasible for people with secondary breast cancer to use an...